Daniel J Levitt - Net Worth and Insider Trading
Daniel J Levitt Net Worth
The estimated net worth of Daniel J Levitt is at least $22,533 dollars as of 2024-11-13. Daniel J Levitt is the VP & Chief Medical Officer of Dynavax Technologies Corp and owns about 1,667 shares of Dynavax Technologies Corp (DVAX) stock worth over $22,505. Daniel J Levitt is the Chief Medical Officer of LadRx Corp and owns about 24 shares of LadRx Corp (LADX) stock worth over $29. Daniel J Levitt is also the Director of Neoleukin Therapeutics Inc and owns about 0 shares of Neoleukin Therapeutics Inc (NLTX) stock worth over $0. Details can be seen in Daniel J Levitt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel J Levitt has not made any transactions after 2018-05-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel J Levitt
Daniel J Levitt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel J Levitt owns 4 companies in total, including Neoleukin Therapeutics Inc (NLTX) , LadRx Corp (LADX) , and Sorrento Therapeutics Inc (SRNE) among others .
Click here to see the complete history of Daniel J Levitt’s form 4 insider trades.
Insider Ownership Summary of Daniel J Levitt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NLTX | Neoleukin Therapeutics Inc | 2018-05-14 | director |
| LADX | LadRx Corp | 2014-01-01 | EVP and Chief Medical Officer |
| SRNE | Sorrento Therapeutics Inc | 2014-01-30 | director |
 | | 2004-02-11 | VP & Chief Medical Officer |
Daniel J Levitt Latest Holdings Summary
Daniel J Levitt currently owns a total of 3 stocks. Among these stocks, Daniel J Levitt owns 1,667 shares of Dynavax Technologies Corp (DVAX) as of February 11, 2004, with a value of $22,505 and a weighting of 99.87%. Daniel J Levitt owns 24 shares of LadRx Corp (LADX) as of February 22, 2012, with a value of $29 and a weighting of 0.13%. Daniel J Levitt also owns 0 shares of Neoleukin Therapeutics Inc (NLTX) as of May 14, 2018, with a value of $0 and a weighting of 0%.
Latest Holdings of Daniel J Levitt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DVAX | Dynavax Technologies Corp | 2004-02-11 | 1,667 | 13.50 | 22,505 |
| LADX | LadRx Corp | 2012-02-22 | 24 | 1.20 | 29 |
| NLTX | Neoleukin Therapeutics Inc | 2018-05-14 | 0 | 3.49 | 0 |
Holding Weightings of Daniel J Levitt
Daniel J Levitt Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel J Levitt has made a total of 0 transactions in Dynavax Technologies Corp (DVAX) over the past 5 years. The most-recent trade in Dynavax Technologies Corp is the sale of 0 shares on February 11, 2004, which brought Daniel J Levitt around $0.
According to the SEC Form 4 filings, Daniel J Levitt has made a total of 0 transactions in LadRx Corp (LADX) over the past 5 years. The most-recent trade in LadRx Corp is the acquisition of 24 shares on February 22, 2012, which cost Daniel J Levitt around $29,000.
According to the SEC Form 4 filings, Daniel J Levitt has made a total of 0 transactions in Neoleukin Therapeutics Inc (NLTX) over the past 5 years. The most-recent trade in Neoleukin Therapeutics Inc is the sale of 195 shares on May 14, 2018, which brought Daniel J Levitt around $49,489.
Insider Trading History of Daniel J Levitt
- 1
Daniel J Levitt Trading Performance
GuruFocus tracks the stock performance after each of Daniel J Levitt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel J Levitt is 38.39%. GuruFocus also compares Daniel J Levitt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel J Levitt within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel J Levitt's insider trading performs compared to the benchmark.
Performance of Daniel J Levitt
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 21.88 | | | | | |
| Relative Return to S&P 500(%) | 19.29 | | | | | |
Daniel J Levitt Ownership Network
Ownership Network List of Daniel J Levitt
Ownership Network Relation of Daniel J Levitt
Daniel J Levitt Owned Company Details
What does Neoleukin Therapeutics Inc do?
Who are the key executives at Neoleukin Therapeutics Inc?
Daniel J Levitt is the director of Neoleukin Therapeutics Inc. Other key executives at Neoleukin Therapeutics Inc include 10 percent owner Baker Bros. Advisors Lp , Principal Accounting Officer Sean Michael Smith , and Chief Medical Officer Priti Patel .
Neoleukin Therapeutics Inc (NLTX) Insider Trades Summary
Over the past 18 months, Daniel J Levitt made no insider transaction in Neoleukin Therapeutics Inc (NLTX). Other recent insider transactions involving Neoleukin Therapeutics Inc (NLTX) include a net purchase of 2,285,342 shares made by Baker Bros. Advisors Lp , and a net sale of 1,323 shares made by Sean Michael Smith .
In summary, during the past 3 months, insiders sold 0 shares of Neoleukin Therapeutics Inc (NLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 66 shares of Neoleukin Therapeutics Inc (NLTX) were sold and 114,267 shares were bought by its insiders, resulting in a net purchase of 114,201 shares.
Neoleukin Therapeutics Inc (NLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neoleukin Therapeutics Inc Insider Transactions
Daniel J Levitt Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel J Levitt. You might contact Daniel J Levitt via mailing address: C/o Dynavax Technologies Corp, 2929 Seventh St Ste 100, Berkeley Ca 94710.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
